Nature Biotechnology is a peer reviewed scientific journal published monthly by the Nature Publishing Group. The chief editor is Andrew Marshall who is part of an in-house team of editors. The focus of the journal is biotechnology including research results and the commercial business sector of this field. Coverage includes the related biological, biomedical, agricultural and environmental sciences. Also of interest are the commercial, political, legal, and societal influences that affect this field.
Measuring modified protein structures
Swiss researchers have developed a new approach to measure proteins with structures that change. This could enable new diagnostic tools for the early recognition of neurodegenerative diseases to be developed.
Simple urine test uses nanotechnology to detect dangerous blood clotting
Life-threatening blood clots can form in anyone who sits on a plane for a long time, is confined to bed while recovering from surgery, or takes certain medications.
Nanopore technique rapidly decodes long DNA strands
(Phys.org) —A low-cost technology may make it possible to read long sequences of DNA far more quickly than current techniques.
Single-cell analysis holds promise for stem cell and cancer research
(Phys.org) —UC San Francisco researchers have identified cells' unique features within the developing human brain, using the latest technologies for analyzing gene activity in individual cells, and have demonstrated that ...
Researchers use microRNA to trap mutant viruses in the lab
Cataloguing 10 million human gut microbial genes
Over the past several years, research on bacteria in the digestive tract (gut microbiome) has confirmed the major role they play in our health. An international consortium, in which INRA participates, has developed the most ...
Retracing early cultivation steps: Lessons from comparing citrus genomes
Citrus is the world's most widely cultivated fruit crop. In the U.S. alone, the citrus crop was valued at over $3.1 billion in 2013. Originally domesticated in Southeast Asia thousands of years ago before spreading throughout ...
New genome-editing platform significantly increases accuracy of CRISPR-based systems
A next-generation genome editing system developed by Massachusetts General Hospital (MGH) investigators substantially decreases the risk of producing unwanted, off-target gene mutations. In a paper receiving online publication ...
DREAM project crowdsources answer to cancer cell drug sensitivities
A study published June 1 in the journal Nature Biotechnology describes the results of an open challenge to predict which breast cancer cell lines will respond to which drugs, based only on the sum of cells' genomic data. ...
New nanoparticle halts multiple sclerosis, now being tested in Type 1 diabetes and asthma
In a breakthrough for nanotechnology and multiple sclerosis, a biodegradable nanoparticle turns out to be the perfect vehicle to stealthily deliver an antigen that tricks the immune system into stopping its attack on myelin ...